logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Atherosclerosis

    FiltersReset Filters
    6 results
    • ezallor sprinkle

      (ROSUVASTATIN)
      Sun Pharmaceutical Industries, Inc.
      Usage: EZALLOR SPRINKLE is indicated to reduce the risk of major adverse cardiovascular events in at-risk adults, lower LDL cholesterol in various hyperlipidemia types, and treat primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It can be used alone or with other LDL-lowering therapies for patients with familial hypercholesterolemia.
    • rosuvastain calcium

      (Rosuvastain Calcium)
      Chartwell RX, LLC
      Usage: Rosuvastatin tablets are indicated to reduce cardiovascular risks in adults without coronary heart disease, lower LDL cholesterol in hyperlipidemia, slow atherosclerosis progression, and treat familial hypercholesterolemia in patients aged 7 years and older, alongside dietary management and adjunct therapies.
    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Cadila Pharmaceuticals Limited
      Usage: Rosuvastatin tablets are indicated to reduce cardiovascular risk in adults without established coronary heart disease and to lower LDL-C levels in adults and children with hyperlipidemia, including those with familial hypercholesterolemia. It also treats primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.
    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Novadoz Pharmaceuticals LLC
      Usage: Rosuvastatin tablets are indicated to reduce the risk of major cardiovascular events in at-risk adults, lower LDL cholesterol in adults and pediatric patients with various types of hyperlipidemia, and treat conditions such as primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.
    • rosuvastatin calcium

      (ROSUVASTATIN CALCIUM)
      PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
      Usage: Rosuvastatin is indicated to treat hyperlipidemia, mixed dyslipidemia, hypertriglyceridemia, primary dysbetalipoproteinemia, and homozygous familial hypercholesterolemia. It aids in slowing atherosclerosis progression and primary prevention of cardiovascular disease in at-risk adults. It should be used alongside dietary management.
    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Rising Pharma Holdings, Inc.
      Usage: Rosuvastatin tablets are indicated to reduce the risk of major cardiovascular events in at-risk adults, lower LDL cholesterol in various conditions (primary hyperlipidemia, heterozygous familial hypercholesterolemia), and treat primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet or other LDL-lowering therapies.